Vimarsana
Biggest News Aggregation in the World

Listing Qualifications Panel News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Listing Qualifications Panel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Listing Qualifications Panel Today - Breaking & Trending Today

NuZee, Inc. Announces NASDAQ-Approved Extension to Regain Compliance with Nasdaq Listing Rule 5550(b) - Vimarsana News

NuZee, Inc. Announces NASDAQ-Approved Extension to Regain Compliance with Nasdaq Listing Rule 5550(b)

VISTA, Calif., April 11, 2024 /PRNewswire/ -- NuZee, Inc. (NASDAQ: NUZE), a leading coffee co-packing and technology company, today announced that it had been granted an extension of time to

NuZee, Inc. Announces NASDAQ-Approved Extension to Regain Compliance with Nasdaq Listing Rule 5550(b) - Vimarsana News

NuZee, Inc. Announces NASDAQ-Approved Extension to Regain Compliance with Nasdaq Listing Rule 5550(b)

/PRNewswire/ -- NuZee, Inc. (NASDAQ: NUZE), a leading coffee co-packing and technology company, today announced that it had been granted an extension of time...

MULN Stock Alert: Mullen Receives Payment from British Airways - Vimarsana News

MULN Stock Alert: Mullen Receives Payment from British Airways

MULN stock is in the spotlight after the electric vehicle company announced that it had received payment from British Airways on Aug. 31.

Mullen Automotive Stock News: share price fights back after attempt to fight NASDAQ delisting - Vimarsana News

Mullen Automotive Stock News: share price fights back after attempt to fight NASDAQ delisting

Mullen Automotive (MULN) stock has gained 1.7% in Friday’s premarket in sharp contrast to the leading equity indices. Part of the reason appears to b

Eloxx Pharmaceuticals Granted Extension by Nasdaq to Regain Compliance with the Market Value of Listed Securities Continued Listing Requirement - Vimarsana News

Eloxx Pharmaceuticals Granted Extension by Nasdaq to Regain Compliance with the Market Value of Listed Securities Continued Listing Requirement

WATERTOWN, Mass., Aug. 03, 2023 -- Eloxx Pharmaceuticals, Inc. , a leader in ribosomal RNA-targeted genetic therapies for rare diseases, today announced that it received notice from the Nasdaq...